Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

NCT04363359 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1980

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: 0.5ml Quadrivalent influenza vaccine
BIOLOGICAL: 0.25ml Quadrivalent influenza vaccine
BIOLOGICAL: 0.25ml Trivalent influenza vaccine(B/V)
BIOLOGICAL: 0.25ml Trivalent influenza vaccine(B/Y)

Sponsor

Shanghai Institute Of Biological Products